Although effect sizes were relatively small, the results highlight the potential of time-skill training to improve daily life functioning in school-age children with ADHD.
The other randomized controlled trial, into the effects of omega-3 supplementation as a treatment for children with ADHD, is a rare example of the placebo condition doing significantly better than the active treatment, even with a clinically relevant effect size [3] . Unfortunately, studies reporting negative results are much less likely to make it into a journal and the fact that data collection for the study had been completed already 7 years ago probably indicates difficulties of getting the paper published. Still, the study is very worthwhile as it has one of the largest samples sizes in this area and was conducted in a double-blinded fashion. The results make one wonder, as the authors appropriately conclude, whether it is worth continuing to perform clinical trials in this field. It certainly suggests that there is no evidence base to apply omega-3 supplementation as a treatment for ADHD in clinical practice.
There is some debate about the precise benefits of methylphenidate treatment for children with ADHD [4] and to what extent prescription of methylphenidate in clinical practice is in line with clinical recommendations. Two of this issue's articles shed light on these important topics around methylphenidate treatment. A study based on Taiwan's large National Health Insurance Research Database clearly indicates protective effects of methylphenidate in reducing traumatic brain injuries, with larger protective effects in relation to increased dosages [5] . It adds to studies pointing to beneficial effects of methylphenidate, e.g., in reducing the risk of substance abuse [6] . The study of Courtabessis et al. [7] in this issue is reassuring in that it indicates that clinicians' treatment decision-making with regard to initiating methylphenidate treatment in a clinic in Montpellier, France, complies well with European clinical guidelines.
Finally, two articles highlight the importance of paying attention to co-occurring problems in ADHD that go beyond well-known associated comorbidities such as oppositional-defiant and conduct disorder. A systematic review and meta-analysis in this issue demonstrates that there is a positive association between ADHD and migraine, but not with tension-type headache [8] . This warrants further studies into possibly shared etiological mechanisms between migraine and ADHD. The last ADHD-related article [9] that I would like to highlight reports surprisingly high rates of significant sleep problems in children with ADHD, i.e., in 75% of girls and over half of boys. Interestingly, specific types of sleep problems appeared to be uniquely related to comorbid conditions such as anxiety symptoms, depression, and oppositional-defiant disorder. As impaired sleep clearly affects day time functioning the article has great relevance for clinical practice. It underlines the importance of systematically assessing each child with ADHD on a broad range of possible co-occurring problems and to carefully plan individualized multimodal treatment.
